Latest On Cidara Therapeutics, Inc (CDTX):
About Cidara Therapeutics, Inc (CDTX):
Cidara Therapeutics, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of novel long-acting anti-infectives for the treatment and prevention of diseases in the United States. The company's lead product candidate is rezafungin acetate, a novel molecule in the echinocandin class of antifungals for the treatment and prevention of serious invasive fungal infections, including candidemia and invasive candidiasis, which are fungal infections associated with high mortality rates. It also advances its Cloudbreak platform to develop antiviral conjugates for the prevention and treatment of influenza and other viral infections, such as RSV, HIV, and the SARS-CoV-2 strains causing COVID-19. The company was formerly known as K2 Therapeutics, Inc. and changed its name to Cidara Therapeutics, Inc. in July 2014. Cidara Therapeutics, Inc. was incorporated in 2012 and is headquartered in San Diego, California.
General
- Name Cidara Therapeutics, Inc
- Symbol CDTX
- Type Common Stock
- Exchange NASDAQ
- Currency USD
- Country USA
- SectorHealthcare
- IndustryBiotechnology
- Full Time Employees 79
- Fiscal Year EndDecember
- IPO Date2015-04-15
- Gic SectorHealth Care
- Gic GroupPharmaceuticals, Biotechnology & Life Sciences
- Gic IndustryBiotechnology
- Gic SubIndustryBiotechnology
- Web URLhttp://www.cidara.com
Valuation
- Price/Sales (Trailing 12 Mt.) 7.89
- Price/Book (Most Recent Quarter) 10.27
- Enterprise Value Revenue 6.8
Financials
- Most Recent Quarter 2020-12-31
- Current Year EPS Estimate -$1.61
- Next Year EPS Estimate -$1.44
- Next Quarter EPS Estimate -$0.31
- Operating Margin -595%
- Return on Assets -69%
- Return on Equity -297%
- Revenue 12.07 million
- Earnings Per Share -$2.14
- Revenue Per Share $0.29
- Gross Profit -55950000
- Quarterly Earnings Growth 105.5%
Highlights
- Market Capitalization 115.78 million
- EBITDA -61577000
- PE Ratio -2.7
- Analyst Target Price $6.83
- Book Value Per Share $0.24
Share Statistics
- Shares Outstanding 48.04 million
- Shares Float 35.28 million
- % Held by Insiders 1754%
- % Held by Institutions 65.31%
- Shares Short 1.6 million
- Shares Short Prior Month 1.59 million
- Short Ratio 1.06
- Short % of Float 4%
- Short % of Shares Outstanding 3%
Technicals
- Beta 1.47
- 52 Week High $4.34
- 52 Week Low $1.82
- 50 Day Moving Average 2.54
- 200 Day Moving Average 2.58
Dividends
- Dividend Date N/A
- ExDividend Date N/A
- Dividend Yield 0%
Cidara Therapeutics, Inc (CDTX) Dividend Calendar:
Ex-Dividend Date | Payment Date | Record Date | Declared Date | Amount |
---|
Cidara Therapeutics, Inc (CDTX) Earnings History:
Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.
Quarter Date | Report Date | Actual Revenue | Reported EPS | EPS Estimate | Deviation from Estimate |
---|---|---|---|---|---|
2020-12-31 | 2021-02-25 | $N/A | -$0.48 | -$0.24 | -100% |
2020-09-30 | 2020-11-05 | $N/A | -$0.41 | -$0.40 | -1.61% |
2020-06-30 | 2020-08-13 | $N/A | -$0.45 | -$0.31 | -44.79% |
2020-03-31 | 2020-05-13 | $2.53 million | -$0.46 | -$0.34 | -35.33% |
2019-12-31 | 2020-03-04 | $1.82 million | -$0.42 | -$0.43 | 3% |
2019-09-30 | 2019-11-08 | $19.1 million | $0.08 | -$0.26 | 131.1% |
2019-06-30 | 2019-08-08 | $N/A | -$0.49 | -$0.57 | 13.31% |
2019-03-31 | 2019-05-09 | $N/A | -$0.60 | -$0.60 | 0.7% |
2018-12-31 | 2019-02-28 | $N/A | -$0.44 | -$0.59 | 24.99% |
2018-09-30 | 2018-11-08 | $N/A | -$0.49 | -$0.60 | 18.67% |
2018-06-30 | 2018-08-08 | $N/A | -$1.13 | -$0.67 | -69.49% |
2018-03-31 | 2018-05-10 | $N/A | -$0.80 | -$0.64 | -24.22% |
2017-12-31 | 2018-02-27 | $N/A | -$0.69 | -$0.75 | 8.17% |
2017-09-30 | 2017-11-08 | $N/A | -$0.73 | -$0.94 | 22.69% |
2017-06-30 | 2017-08-09 | $N/A | -$0.99 | -$0.87 | -13.98% |
2017-03-31 | 2017-05-10 | $N/A | -$0.80 | -$0.88 | 8.95% |
2016-12-31 | 2017-03-15 | $N/A | -$0.88 | -$0.78 | -13.3% |
2016-09-30 | 2016-11-10 | $N/A | -$0.88 | -$0.88 | 0.45% |
2016-06-30 | 2016-08-11 | $N/A | -$0.85 | -$0.77 | -11.11% |
2016-03-31 | 2016-05-12 | $N/A | -$0.71 | -$0.73 | 3.18% |
2015-12-31 | 2016-03-18 | $N/A | -$0.72 | -$0.70 | -2.27% |
2015-09-30 | 2015-11-16 | $N/A | -$0.67 | -$0.57 | -17.54% |
2015-06-30 | 2015-08-11 | $N/A | -$0.59 | -$0.57 | -3.51% |
2015-03-31 | 2015-04-15 | $N/A | -$5.92 | -$0.70 | -745.71% |
Cidara Therapeutics, Inc (CDTX) Company Financial Statements:
Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.
Income Statement:
Date |
---|
Research Development |
Income Before Tax |
Selling General Administrative |
Gross Profit |
Ebit |
Operating Income |
Income Tax Expense |
Total Revenue |
Cost of Revenue |
Total Other Income Expense Net |
Net Income From Continuing Operations |
Net Income Applicable to Common Shares |
Cash Flow:
Date |
---|
Investments |
Change to Liabilities |
Total Cash Flow from Investing Activities |
Net Borrowings |
Total Cash Flow from Financial Activities |
Change to Operating Activities |
Change in Cash |
Total Cash from Operating Activities |
Depreciation |
Other Cash Flow from Investing Activities |
Change to Inventory |
Change to Account Receivables |
Other Cash Flow from Financing Activities |
Change to Net Income |
Capital Expenditures |
Balance Sheet:
Date |
---|
Total Liabailities |
Total Stockholder Equity |
Other Current Liabilities |
Total Assets |
Common Stock |
Other Current Assets |
Retained Earnings |
Other Liabilities |
Other Assets |
Cash |
Total Current Liabilities |
Other Stockholder Equity |
Property, Plant & Equipment |
Total Current Assets |
Long Term Investments |
Net Tangible Assets |
Short Term Investments |
Long Term Debt |
Inventory |
Accounts Payable |
Cidara Therapeutics, Inc (CDTX) Chart:
Cidara Therapeutics, Inc (CDTX) News:
Below you will find a list of latest news for Cidara Therapeutics, Inc (CDTX) from major news sources. You can filter the results to only show news from a specific source.
No recent news available
Cidara Therapeutics, Inc (CDTX) Options:
A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.
Expiration Date | Strike | Last Price | Type | Volume | Open Interest | Implied Volatility | In The Money | Change | Change Percent |
---|---|---|---|---|---|---|---|---|---|
2024-04-19 | 2.5 | 0.04 | CALL | 0 | 45 | 0 | FALSE | 0 | 0 |
2024-04-19 | 5 | 0.03 | CALL | 0 | 4 | 0 | FALSE | 0 | 0 |
2024-04-19 | 7.5 | 0 | CALL | 0 | 0 | 0 | FALSE | 0 | 0 |
2024-04-19 | 2.5 | 0 | PUT | 0 | 0 | 0 | TRUE | 0 | 0 |
2024-04-19 | 5 | 0 | PUT | 0 | 0 | 0 | TRUE | 0 | 0 |
2024-04-19 | 7.5 | 0 | PUT | 0 | 0 | 0 | TRUE | 0 | 0 |
2024-05-17 | 2.5 | 0.05 | CALL | 0 | 41 | 0 | FALSE | 0 | 0 |
2024-05-17 | 5 | 0 | CALL | 0 | 0 | 0 | FALSE | 0 | 0 |
2024-05-17 | 7.5 | 0 | CALL | 0 | 0 | 0 | FALSE | 0 | 0 |
2024-05-17 | 2.5 | 0 | PUT | 0 | 0 | 978.24 | TRUE | 0 | 0 |
2024-05-17 | 5 | 0 | PUT | 0 | 0 | 0 | TRUE | 0 | 0 |
2024-05-17 | 7.5 | 0 | PUT | 0 | 0 | 0 | TRUE | 0 | 0 |
2024-06-21 | 2.5 | 0.05 | CALL | 0 | 1434 | 0 | FALSE | 0 | 0 |
2024-06-21 | 5 | 0.05 | CALL | 0 | 1 | 0 | FALSE | 0 | 0 |
2024-06-21 | 7.5 | 0 | CALL | 0 | 0 | 0 | FALSE | 0 | 0 |
2024-06-21 | 2.5 | 0 | PUT | 0 | 0 | 923.97 | TRUE | 0 | 0 |
2024-06-21 | 5 | 0 | PUT | 0 | 0 | 687.15 | TRUE | 0 | 0 |
2024-06-21 | 7.5 | 0 | PUT | 0 | 0 | 735.47 | TRUE | 0 | 0 |
2024-09-20 | 2.5 | 0.1 | CALL | 48 | 758 | 160.71 | FALSE | 0 | 0 |
2024-09-20 | 5 | 0 | CALL | 0 | 0 | 0 | FALSE | 0 | 0 |
2024-09-20 | 7.5 | 0 | CALL | 0 | 0 | 0 | FALSE | 0 | 0 |
2024-09-20 | 2.5 | 2 | PUT | 0 | 10 | 215.26 | TRUE | 0 | 0 |
2024-09-20 | 5 | 0 | PUT | 0 | 0 | 648.92 | TRUE | 0 | 0 |
2024-09-20 | 7.5 | 0 | PUT | 0 | 0 | 718.22 | TRUE | 0 | 0 |
Latest CDTX Trades:
Date | Shares | Price |
---|---|---|
Jun 13, 2022 7:56 PM EST | 43 | $0.4997 |
Jun 13, 2022 7:56 PM EST | 43 | $0.4997 |
Jun 13, 2022 7:59 PM EST | 200 | $0.5025 |
Jun 13, 2022 7:59 PM EST | 100 | $0.5025 |
Jun 13, 2022 7:59 PM EST | 100 | $0.5025 |
Cidara Therapeutics, Inc (CDTX) SEC Filings:
An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.
Date | Form Type | Form Name | Link |
---|---|---|---|
2020-06-25 | 4/A | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1610618/000120919120039025/0001209191-20-039025-index.htm |
2019-11-26 | UPLOAD | SEC-generated letter | https://www.sec.gov/Archives/edgar/data/1610618/000000000019015876/0000000000-19-015876-index.htm |
2019-12-09 | UPLOAD | SEC-generated letter | https://www.sec.gov/Archives/edgar/data/1610618/000000000019016205/0000000000-19-016205-index.htm |
2020-06-09 | UPLOAD | SEC-generated letter | https://www.sec.gov/Archives/edgar/data/1610618/000000000020005122/0000000000-20-005122-index.htm |
2018-09-10 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1610618/000031506618002315/0000315066-18-002315-index.htm |
2019-09-13 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1610618/000089383819000020/0000893838-19-000020-index.htm |
2018-12-28 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1610618/000092189518003393/0000921895-18-003393-index.htm |
2020-02-14 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1610618/000092189520000528/0000921895-20-000528-index.htm |
2020-02-21 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1610618/000093583620000166/0000935836-20-000166-index.htm |
2019-02-11 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1610618/000095014219000199/0000950142-19-000199-index.htm |
2019-09-03 | 8-K/A | Current report | https://www.sec.gov/Archives/edgar/data/1610618/000114036119015933/0001140361-19-015933-index.htm |
2019-11-20 | SC TO-I | Tender offer statement by Issuer | https://www.sec.gov/Archives/edgar/data/1610618/000114036119020978/0001140361-19-020978-index.htm |
2019-12-04 | CORRESP | Correspondence | https://www.sec.gov/Archives/edgar/data/1610618/000114036119021903/0001140361-19-021903-index.htm |
2019-12-04 | SC TO-I/A | Tender offer statement by Issuer | https://www.sec.gov/Archives/edgar/data/1610618/000114036119021904/0001140361-19-021904-index.htm |
2019-12-10 | CORRESP | Correspondence | https://www.sec.gov/Archives/edgar/data/1610618/000114036119022238/0001140361-19-022238-index.htm |
2019-12-20 | SC TO-I/A | Tender offer statement by Issuer | https://www.sec.gov/Archives/edgar/data/1610618/000114036119022987/0001140361-19-022987-index.htm |
2020-01-10 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1610618/000114036120000607/0001140361-20-000607-index.htm |
2020-01-22 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1610618/000114036120001203/0001140361-20-001203-index.htm |
2020-01-22 | 424B5 | Prospectus [Rule 424(b)(5)] | https://www.sec.gov/Archives/edgar/data/1610618/000114036120001205/0001140361-20-001205-index.htm |
2020-02-07 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1610618/000114036120002603/0001140361-20-002603-index.htm |
2020-02-13 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1610618/000114036120002977/0001140361-20-002977-index.htm |
2020-06-05 | S-3 | Registration statement under Securities Act of 1933 | https://www.sec.gov/Archives/edgar/data/1610618/000114036120013123/0001140361-20-013123-index.htm |
2020-06-11 | S-3/A | Registration statement under Securities Act of 1933 | https://www.sec.gov/Archives/edgar/data/1610618/000114036120013613/0001140361-20-013613-index.htm |
2020-06-11 | CORRESP | Correspondence | https://www.sec.gov/Archives/edgar/data/1610618/000114036120013614/0001140361-20-013614-index.htm |
2020-06-12 | CORRESP | Correspondence | https://www.sec.gov/Archives/edgar/data/1610618/000114036120013693/0001140361-20-013693-index.htm |
2020-06-17 | 424B3 | Prospectus [Rule 424(b)(3)] | https://www.sec.gov/Archives/edgar/data/1610618/000114036120014052/0001140361-20-014052-index.htm |
2020-06-25 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1610618/000114036120014775/0001140361-20-014775-index.htm |
2020-06-25 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1610618/000114036120014777/0001140361-20-014777-index.htm |
2020-06-25 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1610618/000114036120014780/0001140361-20-014780-index.htm |
2020-06-25 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1610618/000114036120014783/0001140361-20-014783-index.htm |
2020-06-25 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1610618/000114036120014785/0001140361-20-014785-index.htm |
2018-11-08 | S-3 | Registration statement under Securities Act of 1933 | https://www.sec.gov/Archives/edgar/data/1610618/000119312518322534/0001193125-18-322534-index.htm |
2018-11-08 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1610618/000119312518322646/0001193125-18-322646-index.htm |
2018-11-13 | SC 13D/A | General statement of acquisition of beneficial ownership | https://www.sec.gov/Archives/edgar/data/1610618/000119312518325665/0001193125-18-325665-index.htm |
2018-11-16 | 424B5 | Prospectus [Rule 424(b)(5)] | https://www.sec.gov/Archives/edgar/data/1610618/000119312518328972/0001193125-18-328972-index.htm |
2019-02-13 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1610618/000119312519037834/0001193125-19-037834-index.htm |
2019-02-13 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1610618/000119312519037869/0001193125-19-037869-index.htm |
2019-02-14 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1610618/000119312519039514/0001193125-19-039514-index.htm |
2019-07-29 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1610618/000119312519204788/0001193125-19-204788-index.htm |
2020-02-14 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1610618/000119312520037526/0001193125-20-037526-index.htm |
2020-02-14 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1610618/000119312520037795/0001193125-20-037795-index.htm |
2018-08-28 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1610618/000120919118048682/0001209191-18-048682-index.htm |
2018-09-12 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1610618/000120919118050649/0001209191-18-050649-index.htm |
2018-09-12 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1610618/000120919118050651/0001209191-18-050651-index.htm |
2018-09-18 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1610618/000120919118051580/0001209191-18-051580-index.htm |
2018-12-04 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1610618/000120919118061046/0001209191-18-061046-index.htm |
2018-12-04 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1610618/000120919118061049/0001209191-18-061049-index.htm |
2018-12-04 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1610618/000120919118061051/0001209191-18-061051-index.htm |
2018-12-04 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1610618/000120919118061058/0001209191-18-061058-index.htm |
2019-02-01 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1610618/000120919119006608/0001209191-19-006608-index.htm |
2019-02-01 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1610618/000120919119006609/0001209191-19-006609-index.htm |
2019-02-01 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1610618/000120919119006610/0001209191-19-006610-index.htm |
2019-02-01 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1610618/000120919119006611/0001209191-19-006611-index.htm |
2019-02-01 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1610618/000120919119006613/0001209191-19-006613-index.htm |
2019-03-08 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1610618/000120919119018293/0001209191-19-018293-index.htm |
2019-03-08 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1610618/000120919119018294/0001209191-19-018294-index.htm |
2019-03-13 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1610618/000120919119019068/0001209191-19-019068-index.htm |
2019-03-22 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1610618/000120919119021003/0001209191-19-021003-index.htm |
2019-03-22 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1610618/000120919119021005/0001209191-19-021005-index.htm |
2019-03-22 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1610618/000120919119021007/0001209191-19-021007-index.htm |
2019-03-22 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1610618/000120919119021008/0001209191-19-021008-index.htm |
2019-03-22 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1610618/000120919119021009/0001209191-19-021009-index.htm |
2019-06-27 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1610618/000120919119039293/0001209191-19-039293-index.htm |
2019-06-27 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1610618/000120919119039294/0001209191-19-039294-index.htm |
2019-06-27 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1610618/000120919119039295/0001209191-19-039295-index.htm |
2019-06-27 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1610618/000120919119039296/0001209191-19-039296-index.htm |
2019-06-27 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1610618/000120919119039301/0001209191-19-039301-index.htm |
2019-09-16 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1610618/000120919119049672/0001209191-19-049672-index.htm |
2019-09-16 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1610618/000120919119049681/0001209191-19-049681-index.htm |
2019-09-16 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1610618/000120919119049684/0001209191-19-049684-index.htm |
2019-09-16 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1610618/000120919119049685/0001209191-19-049685-index.htm |
2019-09-16 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1610618/000120919119049694/0001209191-19-049694-index.htm |
2019-09-26 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1610618/000120919119050922/0001209191-19-050922-index.htm |
2019-09-26 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1610618/000120919119050923/0001209191-19-050923-index.htm |
2019-10-01 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1610618/000120919119051327/0001209191-19-051327-index.htm |
2019-10-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1610618/000120919119052479/0001209191-19-052479-index.htm |
2019-10-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1610618/000120919119052480/0001209191-19-052480-index.htm |
2019-12-20 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1610618/000120919119061574/0001209191-19-061574-index.htm |
2019-12-20 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1610618/000120919119061576/0001209191-19-061576-index.htm |
2019-12-20 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1610618/000120919119061579/0001209191-19-061579-index.htm |
2020-01-06 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1610618/000120919120002030/0001209191-20-002030-index.htm |
2020-01-06 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1610618/000120919120002034/0001209191-20-002034-index.htm |
2020-01-06 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1610618/000120919120002038/0001209191-20-002038-index.htm |
2020-01-30 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1610618/000120919120005704/0001209191-20-005704-index.htm |
2020-01-30 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1610618/000120919120005705/0001209191-20-005705-index.htm |
2020-02-11 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1610618/000120919120008463/0001209191-20-008463-index.htm |
2020-03-23 | 4/A | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1610618/000120919120020744/0001209191-20-020744-index.htm |
2020-03-23 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1610618/000120919120020747/0001209191-20-020747-index.htm |
2020-03-23 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1610618/000120919120020751/0001209191-20-020751-index.htm |
2020-03-23 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1610618/000120919120020753/0001209191-20-020753-index.htm |
2020-03-23 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1610618/000120919120020754/0001209191-20-020754-index.htm |
2020-03-23 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1610618/000120919120020755/0001209191-20-020755-index.htm |
2020-03-23 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1610618/000120919120020756/0001209191-20-020756-index.htm |
2020-06-25 | 4/A | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1610618/000120919120039024/0001209191-20-039024-index.htm |
2020-06-25 | 4/A | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1610618/000120919120039025/0001209191-20-039025-index.htm |
2019-02-14 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1610618/000149315219002117/0001493152-19-002117-index.htm |
2020-02-14 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1610618/000149315220002530/0001493152-20-002530-index.htm |
2020-02-21 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1610618/000149315220002833/0001493152-20-002833-index.htm |
2019-09-13 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1610618/000156761919018258/0001567619-19-018258-index.htm |
2018-08-09 | 10-Q/A | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1610618/000161061818000087/0001610618-18-000087-index.htm |
2018-08-09 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1610618/000161061818000088/0001610618-18-000088-index.htm |
2018-08-09 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1610618/000161061818000089/0001610618-18-000089-index.htm |
2018-08-17 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1610618/000161061818000092/0001610618-18-000092-index.htm |
2018-09-12 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1610618/000161061818000095/0001610618-18-000095-index.htm |
2018-11-08 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1610618/000161061818000109/0001610618-18-000109-index.htm |
2018-11-08 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1610618/000161061818000110/0001610618-18-000110-index.htm |
2018-11-08 | S-8 | Securities to be offered to employees in employee benefit plans | https://www.sec.gov/Archives/edgar/data/1610618/000161061818000111/0001610618-18-000111-index.htm |
2018-12-03 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1610618/000161061818000118/0001610618-18-000118-index.htm |
2019-02-28 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1610618/000161061819000010/0001610618-19-000010-index.htm |
2019-02-28 | 10-K | Annual report [Section 13 and 15(d), not S-K Item 405] | https://www.sec.gov/Archives/edgar/data/1610618/000161061819000012/0001610618-19-000012-index.htm |
2019-03-22 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1610618/000161061819000016/0001610618-19-000016-index.htm |
2019-04-26 | DEF 14A | Other definitive proxy statements | https://www.sec.gov/Archives/edgar/data/1610618/000161061819000022/0001610618-19-000022-index.htm |
2019-04-26 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material | https://www.sec.gov/Archives/edgar/data/1610618/000161061819000024/0001610618-19-000024-index.htm |
2019-05-09 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1610618/000161061819000033/0001610618-19-000033-index.htm |
2019-05-09 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1610618/000161061819000035/0001610618-19-000035-index.htm |
2019-05-09 | S-8 | Securities to be offered to employees in employee benefit plans | https://www.sec.gov/Archives/edgar/data/1610618/000161061819000036/0001610618-19-000036-index.htm |
2019-06-17 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1610618/000161061819000040/0001610618-19-000040-index.htm |
2019-07-29 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1610618/000161061819000043/0001610618-19-000043-index.htm |
2019-08-08 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1610618/000161061819000050/0001610618-19-000050-index.htm |
2019-08-08 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1610618/000161061819000051/0001610618-19-000051-index.htm |
2019-08-14 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1610618/000161061819000055/0001610618-19-000055-index.htm |
2019-08-29 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1610618/000161061819000060/0001610618-19-000060-index.htm |
2019-09-03 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1610618/000161061819000062/0001610618-19-000062-index.htm |
2019-09-05 | 8-K/A | Current report | https://www.sec.gov/Archives/edgar/data/1610618/000161061819000065/0001610618-19-000065-index.htm |
2019-09-13 | D | Notice of Exempt Offering of Securities | https://www.sec.gov/Archives/edgar/data/1610618/000161061819000067/0001610618-19-000067-index.htm |
2019-11-08 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1610618/000161061819000076/0001610618-19-000076-index.htm |
2019-11-08 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1610618/000161061819000078/0001610618-19-000078-index.htm |
2019-11-14 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1610618/000161061819000081/0001610618-19-000081-index.htm |
2020-01-13 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1610618/000161061820000004/0001610618-20-000004-index.htm |
2020-03-04 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1610618/000161061820000010/0001610618-20-000010-index.htm |
2020-03-04 | 10-K | Annual report [Section 13 and 15(d), not S-K Item 405] | https://www.sec.gov/Archives/edgar/data/1610618/000161061820000011/0001610618-20-000011-index.htm |
2020-03-04 | S-8 | Securities to be offered to employees in employee benefit plans | https://www.sec.gov/Archives/edgar/data/1610618/000161061820000012/0001610618-20-000012-index.htm |
2020-04-01 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1610618/000161061820000014/0001610618-20-000014-index.htm |
2020-04-14 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1610618/000161061820000018/0001610618-20-000018-index.htm |
2020-04-29 | DEF 14A | Other definitive proxy statements | https://www.sec.gov/Archives/edgar/data/1610618/000161061820000025/0001610618-20-000025-index.htm |
2020-04-29 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material | https://www.sec.gov/Archives/edgar/data/1610618/000161061820000026/0001610618-20-000026-index.htm |
2020-05-13 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1610618/000161061820000034/0001610618-20-000034-index.htm |
2020-05-13 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1610618/000161061820000035/0001610618-20-000035-index.htm |
2020-05-20 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1610618/000161061820000037/0001610618-20-000037-index.htm |
2020-06-25 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1610618/000161061820000040/0001610618-20-000040-index.htm |
2020-08-13 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1610618/000161061820000049/0001610618-20-000049-index.htm |
2020-08-13 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1610618/000161061820000050/0001610618-20-000050-index.htm |
2020-11-05 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1610618/000161061820000057/0001610618-20-000057-index.htm |
2020-11-05 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1610618/000161061820000058/0001610618-20-000058-index.htm |
2018-11-15 | EFFECT | Notice of Effectiveness | https://www.sec.gov/Archives/edgar/data/1610618/999999999518002907/9999999995-18-002907-index.htm |
2020-06-16 | EFFECT | Notice of Effectiveness | https://www.sec.gov/Archives/edgar/data/1610618/999999999520001447/9999999995-20-001447-index.htm |
Cidara Therapeutics, Inc (CDTX) Insider Transactions:
Here you will find a list of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Cidara Therapeutics, Inc (CDTX). Company insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.Insider Ownership: 1754%Institutional Ownership: 6531%
Transaction Date | Insider Name | Insider Title | Type | Shares Number | Shares Price | Total Transaction | Shares Held After Transaction | Link |
---|---|---|---|---|---|---|---|---|
2019-09-24 | James E. Levine | Chief Financial Officer | Buy | 30,000.00 | 1.91 | 57,240.00 | 205,000.00 | https://www.sec.gov/Archives/edgar/data/1610618/000120919119050922/0001209191-19-050922-index.htm |
2019-09-24 | Jeffrey Stein | President & CEO | Buy | 52,500.00 | 1.91 | 100,101.75 | 225,619.00 | https://www.sec.gov/Archives/edgar/data/1610618/000120919119050923/0001209191-19-050923-index.htm |
2019-09-12 | Jeffrey Stein | President & CEO | Buy | 10,000.00 | 282,320.00 | https://www.sec.gov/Archives/edgar/data/1610618/000120919119049694/0001209191-19-049694-index.htm | ||
2019-03-08 | Neil Abdollahian | Chief Business Officer | Sell | 2,300.00 | 2.44 | 5,612.00 | 30,472.00 | https://www.sec.gov/Archives/edgar/data/1610618/000120919119018294/0001209191-19-018294-index.htm |
2019-01-31 | Neil Abdollahian | Chief Business Officer | Buy | 6,000.00 | 32,772.00 | https://www.sec.gov/Archives/edgar/data/1610618/000120919119006613/0001209191-19-006613-index.htm | ||
2019-03-07 | Paul Daruwala | Chief Operating Officer | Sell | 2,240.00 | 2.55 | 5,713.57 | 49,567.00 | https://www.sec.gov/Archives/edgar/data/1610618/000120919119018293/0001209191-19-018293-index.htm |
2019-10-01 | Neil Abdollahian | Chief Business Officer | Sell | 7,284.00 | 1.98 | 14,422.32 | 49,588.00 | https://www.sec.gov/Archives/edgar/data/1610618/000120919119052479/0001209191-19-052479-index.htm |
2019-01-31 | Taylor Sandison | Chief Medical Officer | Buy | 6,000.00 | 50,722.00 | https://www.sec.gov/Archives/edgar/data/1610618/000120919119006611/0001209191-19-006611-index.htm | ||
2020-01-03 | Neil Abdollahian | Chief Business Officer | Sell | 2,340.00 | 3.42 | 8,002.80 | 51,248.00 | https://www.sec.gov/Archives/edgar/data/1610618/000120919120002034/0001209191-20-002034-index.htm |
2019-01-31 | Paul Daruwala | Chief Operating Officer | Buy | 6,000.00 | 51,807.00 | https://www.sec.gov/Archives/edgar/data/1610618/000120919119006608/0001209191-19-006608-index.htm | ||
2019-09-12 | Neil Abdollahian | Chief Business Officer | Buy | 17,500.00 | 51,972.00 | https://www.sec.gov/Archives/edgar/data/1610618/000120919119049681/0001209191-19-049681-index.htm | ||
2020-01-03 | Paul Daruwala | Chief Operating Officer | Sell | 2,340.00 | 3.42 | 8,002.80 | 53,532.00 | https://www.sec.gov/Archives/edgar/data/1610618/000120919120002030/0001209191-20-002030-index.htm |
2019-10-02 | Paul Daruwala | Chief Operating Officer | Sell | 3,295.00 | 1.88 | 6,194.60 | 55,872.00 | https://www.sec.gov/Archives/edgar/data/1610618/000120919119052480/0001209191-19-052480-index.htm |
2019-09-12 | Neil Abdollahian | Chief Business Officer | Buy | 4,900.00 | 56,872.00 | https://www.sec.gov/Archives/edgar/data/1610618/000120919119049681/0001209191-19-049681-index.htm | ||
2019-09-12 | Paul Daruwala | Chief Operating Officer | Buy | 7,500.00 | 57,067.00 | https://www.sec.gov/Archives/edgar/data/1610618/000120919119049672/0001209191-19-049672-index.htm | ||
2019-09-12 | Taylor Sandison | Chief Medical Officer | Buy | 2,500.00 | 57,222.00 | https://www.sec.gov/Archives/edgar/data/1610618/000120919119049685/0001209191-19-049685-index.htm | ||
2019-09-12 | Taylor Sandison | Chief Medical Officer | Buy | 1,400.00 | 58,622.00 | https://www.sec.gov/Archives/edgar/data/1610618/000120919119049685/0001209191-19-049685-index.htm | ||
2019-09-12 | Paul Daruwala | Chief Operating Officer | Buy | 2,100.00 | 59,167.00 | https://www.sec.gov/Archives/edgar/data/1610618/000120919119049672/0001209191-19-049672-index.htm | ||
2019-01-31 | Jessica Oien | General Counsel & Secretary | Buy | 6,000.00 | 6,000.00 | https://www.sec.gov/Archives/edgar/data/1610618/000120919119006609/0001209191-19-006609-index.htm | ||
2020-03-19 | James E. Levine | Chief Financial Officer | Buy | 25,000.00 | 61,891.00 | https://www.sec.gov/Archives/edgar/data/1610618/000120919120020747/0001209191-20-020747-index.htm | ||
2020-01-02 | Jessica Oien | General Counsel & Secretary | Sell | 834.00 | 3.86 | 3,219.24 | 6,965.00 | https://www.sec.gov/Archives/edgar/data/1610618/000120919120002038/0001209191-20-002038-index.htm |
2019-09-27 | Jessica Oien | General Counsel & Secretary | Sell | 1,001.00 | 1.86 | 1,861.86 | 7,799.00 | https://www.sec.gov/Archives/edgar/data/1610618/000120919119051327/0001209191-19-051327-index.htm |
2019-09-12 | Jessica Oien | General Counsel & Secretary | Buy | 2,800.00 | 8,800.00 | https://www.sec.gov/Archives/edgar/data/1610618/000120919119049684/0001209191-19-049684-index.htm |